https://www.selleckchem.com/pr....oducts/tiplaxtinin-p
A new layer was less frequently found at 1 year in patients treated with GPI than in those without GPI (25.0% vs. 58.8%, p = 0.019). Group A, compared to Group B, was associated with a greater increase in area stenosis (19.0 ± 16.4% vs. 3.7 ± 7.1%; p less then 0.001). Potent platelet inhibition with GPI in patients with ACS caused by plaque erosion was associated with lower incidence of new layer formation and less plaque progression.The objectives of this study are to (1) characterize patterns of preventive behaviors 3 mo
Like
Comment
Share
